Chardan Capital analyst Brian Dobson reiterates PLBY Group (NASDAQ:PLBY) with a Buy and maintains $5 price target.
Graybug Vision Granted U.S. Patent Titled ‘EQUATORIALLY MODIFIED POLYMER LINKED MULTIMERS (FOR RETINAL, NEURONAL OR NEURODEGENERATIVE DISEASES)’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11407781&OS=11407781&RS=11407781
